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DiGeorge syndrome is characterised by craniofacial, cardio-
vascular and thymic and parathyroid defects resulting from a
heterozygous 3Mb deletion of chromosome 22q11 in most
patients. Haploinsufficiency of the TBX1 transcription factor is
considered to be the major underlying cause of this syndrome.
Heterozygous mouse models in which a region of MMU16
homologous to HSA22q11 is deleted (Df1) and Tbx1+/− mice
exhibit aortic arch, thymic and parathyroid defects; Tbx1−/−mice
display more severe defects of pharyngeal development. In order
to more clearly define cell autonomous effects of Tbx1 and
circumvent problems associated with tissue loss, we have
developed a novel method of comparing Tbx1 cells. The Tbx1
null allele was generated by knocking in a lacZ reporter gene into
exon 5. Using a fluorescent lacZ substrate, we have isolated
specific Tbx1 cells by FACS and compared the expression profile
of Df1/Tbx1lacZ cells to Tbx1+/lacZ cells by microarray. Down-
regulation of hemizygous Df1 genes confirmed the sensitivity of
the microarray experiment and novel potential transcriptional
targets of Tbx1 have been identified including Nkx2.6, Dab2 and
Hes1, a downstream effector of Notch signalling. Analysis of
Hes1 mouse mutants has led to the characterisation of
DiGeorge-like craniofacial, heart and glandular defects. The
genetic interaction between Hes1 and Tbx1 is currently being
investigated by crossing transgenic mouse mutants and conduct-
ing morpholino knockdown studies in zebrafish.
doi:10.1016/j.ydbio.2007.03.136
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CHARGE syndrome is a multiple malformation syndrome,
with characteristic anomalies including inner and outer ear
defects and cardiovascular malformations. The CHD7 gene on
chromosome 8q12.1 was recently identified as a candidate gene
and mutations are found in approximately 60% of patients. We
show that insertion of a genetrap cassette within the murine
Chd7 gene results in a mouse model of the syndrome with a
heart phenotype consistent with that observed in the human
condition. We have analysed the expression of the Chd7 gene
throughout embryonic development. Homozygous embryos do
not survive beyond 10.5 dpc. In heterozygous embryos early
growth and remodelling defects in the pharyngeal arch arteries
are detected explaining the later complex heart phenotype
consisting of rearrangements in the aortic arch and great vessels.
The heart phenotype overlaps with that seen in DiGeorge
syndrome, another congenital disease where many of the
associated defects are due to abnormal patterning of the
pharyngeal arches as shown in the Tbx1 mouse model.
Examination of Chd7+/−/Tbx1/+/− trans-heterozygous embryos
reveals an increased penetrance of anomalies resulting from
defective pharyngeal arch development, suggesting an epistatic
interaction between the two genes in this region. We also
demonstrate that Wnt1 driven restoration of Chd7 expression in
neural crest cells in an otherwise heterozygous embryo does not
rescue the arch artery defects, contrary to hypotheses proposing
the syndrome is due to irregularities in this population of cells.
doi:10.1016/j.ydbio.2007.03.137
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We have shown that genes for both synthesis and cata-
bolization of retinoic acid (RA), Raldh2 and Cyp26a1, b1 and
c1, are altered in E9.5 Tbx1 null mice compared to wildtype,
and thus are putative Tbx1 target genes. Blockade of Cyp26
function in the chick using R115866, a specific inhibitor of
Cyp26 enzyme function, resulted in a dose-dependent pheno-
copy of the Tbx1 null mouse including loss of caudal
pharyngeal arches and arch arteries and DGS-like heart defects
such as common arterial trunk and ventricular septal defects.
Molecular markers revealed patterning defects within the
pharyngeal tissues and the secondary heart field consistent
with altered RA levels. We are using the zebrafish as a model
system to test the genetic interaction of Tbx1 and these
members of the retinoic acid pathway and other putative Tbx1
target genes, for example Notch family members. Our data
show epistasis between Tbx1 and Cyp26a1 in the zebrafish and
the other Cyp26 family members/targets are currently being
tested. Further, we are investigating whether this effect upon the
RA pathway is achieved only by down-regulation of Tbx1 itself
or whether perturbation of other Tbx1 target genes alone can
also produce this phenotype. Together, these data support the
hypothesis that the dysregulation of RA controlled morphogen-
esis contributes to the Tbx1 loss-of-function phenotype.
Funding: British Heart Foundation.
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Retinoic acid (RA) signaling is critical for cardiac morpho-
genesis. The aim of the present study was to investigate the
relationship between genetic variation at the RALDH2
(ALDH1A2) locus and congenital heart disease (CHD). We
screened the RALDH2 gene of 50 patients with tetralogy of
Fallot and found a silent mutation (A151G) at exon 4, which
encodes sequences involved in tetramerization. A151G is a
polymorphism that disrupts a putative SF2/ASF binding site,
which may act as an exonic splicing enhancer (ESE). To test this
possibility we performed functional splicing studies and
determined that the A151G is associated with a 9% decrease
in exon 4 retention. This small difference may be relevant since
failure to retain exon 4 is associated with frame shifts that lead
to a non-functional protein. Moreover, A151G is also associated
with substantial changes in mRNA secondary structure that may
affect transcript stability. Since A151G has been associated to
spina bifida we tested whether A151G and other 5 polymorphic
markers are associated with CHD. Association studies with
TDT (transmission disequilibrium test) in 101 patient–parent
trios, using single markers or haplotypes, did not show
significant association with CHD. In summary, we cannot yet
establish association between CHD and genetic variation at the
RALDH2 locus in human. Potential functional genetic variants
should be further studied in order to define their real role in RA
pathway disturbances in human.
doi:10.1016/j.ydbio.2007.03.139
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Ts65Dn is the mouse model most widely used in Down
syndrome (DS) research. In this model, triplication of the distal
portion of mouse chromosome 16 (Mmu16), which contains
orthologs to human chromosome 21, results in cardiac defects
reminiscent of DS congenital heart disease. In our study,
embryonic cardiovascular development was examined at stages
critical for septation in order to investigate the spatial and
temporal origins of cardiovascular deformities, such as right
aortic arch and septal defects, previously identified in neonatal
Ts65Dn mice. The branchial arch arteries, which later become
the great thoracic vessels, were malformed at 10.5 day post
coitum in the Ts65Dn embryos. During remodeling of the
endocardial cushions, the amount of apoptosis in the atrioven-
tricular region and the outflow tract was reduced in Ts65Dn
compared to euploid embryos. Immunohistology may indicate
variation in the protein expression within the endocardial
cushions. These findings suggest developmental origins for the
cardiac anomalies seen in Ts65Dn newborn mice and reflect
malformations of vascular structures.
doi:10.1016/j.ydbio.2007.03.140
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